GE HealthCare Technologies Inc. (GEHC) Stock Analysis

Company Overview

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions utilized for the diagnosis, treatment, and monitoring of patients across the United States, Canada, and international markets. The company operates within the Healthcare sector and specifically functions in the Medical Devices industry, providing essential infrastructure for patient care environments. As of the latest reported data, the organization employs approximately 54,000 individuals and holds a market capitalization of $31.59B. This valuation places the company among the larger entities in its field, while the annual revenue of $20.63B indicates a significant operational footprint and substantial market share within the global medical technology landscape.

Financial Health

The company reported a trailing twelve-month revenue of $20.63B and generated net income of $2.08B, with an EBITDA of $3.64B. The difference between the $20.63B revenue and the $2.08B net income highlights a significant cost structure, including operating expenses, taxes, and interest costs that consume a considerable portion of gross receipts. Operating free cash flow stands at $1.69B, which suggests the company maintains a robust capacity to fund capital expenditures, reduce debt, or pursue strategic acquisitions without relying heavily on external financing. The firm reports a gross margin of 40.0%, reflecting the high pricing power and efficiency in producing medical equipment, while an operating margin of 15.7% indicates effective control over administrative and selling expenses. A profit margin of 10.1% further demonstrates the final profitability after all costs are deducted from sales. In terms of leverage, the company holds $4.49B in cash against $10.46B in total debt, resulting in a debt-to-equity ratio of 98.72. This balance sheet structure indicates a leveraged position where long-term liabilities are nearly equal to shareholders' equity. Short-term liquidity is assessed via a current ratio of 1.37, suggesting the company has sufficient current assets to cover its current liabilities. Management effectiveness is highlighted by a Return on Equity of 22.4% and a Return on Assets of 5.5%, showing that the company generates substantial returns for shareholders relative to the equity invested.

Valuation Assessment

The trailing twelve-month P/E ratio is 15.22, while the forward P/E is 12.44. The discrepancy between these two metrics implies that the market expects earnings to increase significantly in the future, as the forward multiple is lower than the trailing multiple. The price-to-book ratio stands at 3.04, indicating that the market values the company at a premium of roughly three times its net asset value. Additionally, the price-to-sales ratio is 1.53 and the EV/EBITDA is 10.36, which suggests the stock is valued moderately relative to its sales volume and enterprise earnings before interest, taxes, depreciation, and amortization. The stock has traded between a 52-week low of $57.65 and a 52-week high of $89.77. Without a specific current price provided in the facts, the valuation range is defined strictly by these historical bounds, illustrating the volatility and trading bands investors must consider. The beta value is 1.18, which means the stock's price volatility is 18% higher than the broader market, exposing investors to greater systemic risk during market downturns.

Growth & Income

Revenue growth over the trailing twelve months is 7.1%, whereas earnings growth over the same period is -17.7%. This divergence indicates that while the top line is expanding, net income has contracted, suggesting that earnings are growing slower than revenue and potentially signaling rising costs or one-time charges impacting profitability. The company reports a dividend yield of 0.2% with a payout ratio of 3.1%. Given the low payout ratio relative to the current earnings, the dividend appears sustainable, though the yield is minimal. The low payout ratio implies that the company retains the vast majority of its earnings rather than distributing them to shareholders. The overall growth and income profile is characterized by steady revenue expansion paired with a significant decline in earnings growth and a negligible dividend return.